View More Recent Stories

Sep 26, 2024 08:33AM Allogene Therapeutics (ALLO) to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases
Aug 7, 2024 04:04PM Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS
Jul 16, 2024 02:06PM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)
Jun 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)
View More Recent Stories